Phil Skolnick, Ph.D., D.Sc. (hon.)

National Institutes of Health, Bethesda, MD 
anxiolytic drugs, GABA Receptors, glutamate, benzodiazepines, antidepressants, NMDA receptor
"Phil Skolnick"
Mean distance: 15.7 (cluster 7)


Sign in to add mentor
John W. Daly post-doc 1972-1977 NIH - NIDDK


Sign in to add trainee
Esther Fride post-doc
Richard Thomas Layer post-doc NIDDK
Piotr Popik post-doc Institute of Pharmacology, Polish Academy of Sciences
Ben Avi Weissman post-doc NIDDK, NIH
Garry Wong post-doc NIH
Todd D. McIntyre post-doc 1986-1990 NIDDK, NIH
Ramon Trullas post-doc 1985-1991 NIDDK
Ian A. Paul post-doc 1989-1993 NIDDK
Li-Ming Zhou post-doc 1992-1994 NIDDK, NIH
Yoshitatsu Sei post-doc 1988-1995 NIDDK
Anthony S. Basile post-doc 1984-1996 NIDDK, NIH
Norman Huang post-doc 1995-1997 NIDDK, NIH
Pierre-Alain Boyer post-doc 1996-1997 NIDDK
Hong Yu research scientist 1997-2001 Eli Lilly & Co
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Krieter P, Gyaw S, Crystal R, et al. (2019) Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose. The Journal of Pharmacology and Experimental Therapeutics
Krieter P, Gyaw S, Chiang CN, et al. (2019) Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose. Journal of Clinical Pharmacology
Bespalov A, Steckler T, Altevogt B, et al. (2016) Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets. Nature Reviews. Drug Discovery
Krieter P, Chiang N, Gyaw S, et al. (2016) Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose. Journal of Clinical Pharmacology
Skolnick P. (2015) Biologic Approaches to Treat Substance-Use Disorders. Trends in Pharmacological Sciences. 36: 628-35
Skolnick P, Kos T, Czekaj J, et al. (2015) Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27: 228-34
Popik P, Holuj M, Nikiforuk A, et al. (2015) 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38
Skolnick P, White D, Acri JB. (2015) Emerging targets for stimulant use disorders: Where to invest in an era of constrained resources? Cns and Neurological Disorders - Drug Targets. 14: 691
Skolnick P, White D, Acri JB. (2015) Synopsis of expert opinions and conclusions Cns and Neurological Disorders - Drug Targets. 14: 773-776
Skolnick P, Davis H, Arnelle D, et al. (2014) Translational potential of naloxone and naltrexone as TLR4 antagonists. Trends in Pharmacological Sciences. 35: 431-2
See more...